AAO Decisions Explorer · Free
Published AAO appeal decisions
Search the decisions the Administrative Appeals Office has published, narrow them by visa, criterion, field and year, and read our summary of each one with a link to the official PDF.

Decisions in the library
6,586
6,586 classified
Visa types
3
Years covered
2005-2026
Latest decision
Aug 31, 2026
Filters
14 decisions
Outcomes in these results
- Dismissed
- Remanded
- Sustained
- EB-2 NIWBiotech and pharmaDec 2024Sustained
A physician-researcher pursuing a Ph.D. in biomedical sciences seeks NIW for research on breast cancer biomarkers and early detection. The petitioner claimed three Dhanasar prongs. The AAO sustained the appeal, finding the proposed research has substantial merit and national importance, the petitioner is well-positioned to advance it given his medical degree and publication record, and waiving job offer requirements would benefit the United States.
3 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaNov 2024Dismissed
Biomedical engineer researcher proposed postdoctoral research on brain cognitive processes using machine learning. AAO withdrew denial of prong one, finding national importance, but affirmed denial under prong two because petitioner lacked demonstrated influence or record of success advancing the field.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaOct 2024Sustained
Electrical engineer and medical imaging researcher with Ph.D. in ultrasound diagnostic analysis sought EB-2 with national interest waiver. Claimed research has broad field implications. AAO sustained, finding all three Dhanasar prongs met: substantial merit and national importance demonstrated, well-positioned given Ph.D. and track record, and U.S. balance favored waiver.
3 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaSep 2024Dismissed
Researcher with advanced degree seeking national interest waiver to develop biomedical instruments and enhance ECMO technology. Director and AAO found petitioner failed to establish that specific proposed endeavor has national importance, focusing on industry importance rather than endeavor-specific prospective impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2024Dismissed
A bioengineer and prosthetics researcher sought EB-2 classification with a national interest waiver. The AAO dismissed the appeal, finding she failed to establish a U.S. bachelor's or advanced degree equivalent and, even under exceptional ability, did not meet three evidentiary criteria. The proposed endeavor lacked specific evidence of national importance.
0 of 3 criteria metRead → - EB-1ABiotech and pharmaAug 2024Dismissed
Pharmaceutical microbiology production manager seeking EB-1A extraordinary ability classification. AAO found petitioner did not meet initial evidence requirements; failed to establish three alternate criteria. Awards lacked documented recognition for field excellence; published material insufficient; no sustained national or international acclaim demonstrated.
0 of 11 criteria metRead → - EB-2 NIWBiotech and pharmaAug 2024Dismissed
Bioanalyst and high school teacher seeking NIW for consulting business in bioanalysis and STEM education. Claimed endeavor would advance science education and economic growth. AAO dismissed appeal, finding proposed endeavor lacked national importance and petitioner not well-positioned to advance it.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJul 2024Dismissed
A pharmaceutical industrial production manager sought EB-2 classification with national interest waiver to plan and direct manufacturing operations. The AAO found the proposed endeavor had substantial merit but lacked national importance, as providing services for one employer would not generate significant economic activity or employment potential at national scale.
0 of 3 criteria metRead → - EB-1ABiotech and pharmaJul 2024Dismissed
A biomedical engineer researcher sought EB-1A classification. The AAO affirmed that he met three initial criteria but dismissed his appeal, finding he failed to demonstrate sustained national or international acclaim or that he ranks among the very top of his field despite accomplishments.
3 of 4 criteria metRead → - EB-2 NIWBiotech and pharmaApr 2024Dismissed
Pharmacist and entrepreneur sought NIW to operate business providing parenteral nutrition products. AAO affirmed denial, finding petitioner failed to describe proposed endeavor with sufficient specificity and provide corroborating evidence that business activities would achieve substantial national economic impact.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaApr 2024Sustained
A researcher in cancer therapeutics using biotechnology tools sought EB-2 national interest waiver. The AAO sustained the appeal, finding the proposed research demonstrated substantial merit and national importance, the petitioner was well positioned to advance it, and on balance waiving the job offer would benefit the United States.
3 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaMar 2024Dismissed
Bioengineering technology researcher seeking NIW for EB-2. AAO agreed endeavor has national importance but held she is not well-positioned to advance it because her research lacks substantial citations, field impact, and evidence of obtaining funding, failing the second Dhanasar prong.
1 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaFeb 2024Dismissed
Pharmaceutical professional seeking EB-2 exceptional ability classification and national interest waiver. AAO dismissed appeal because petitioner failed to meet three initial evidentiary criteria for exceptional ability and did not establish specific endeavor or its prospective national importance under Dhanasar framework.
0 of 3 criteria metRead → - EB-2 NIWBiotech and pharmaJan 2024Dismissed
An entrepreneur with pharmacy and diagnostic laboratory expertise seeks EB-2 NIW to open a low-cost diagnostic lab in an economically depressed region. AAO dismissed because the proposed endeavor lacks national importance; a small business serving local patients and employing 22 workers does not meet Dhanasar's requirement for broader field impact or substantial national economic benefit.
0 of 3 criteria metRead →
